Details for New Drug Application (NDA): 021222
✉ Email this page to a colleague
The generic ingredient in SPECTRACEF is cefditoren pivoxil. There are six drug master file entries for this compound. Additional details are available on the cefditoren pivoxil profile page.
Summary for 021222
Tradename: | SPECTRACEF |
Applicant: | Vansen Pharma |
Ingredient: | cefditoren pivoxil |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 200MG | ||||
Approval Date: | Aug 29, 2001 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 400MG | ||||
Approval Date: | Jul 21, 2008 | TE: | RLD: | No |
Expired US Patents for NDA 021222
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Vansen Pharma | SPECTRACEF | cefditoren pivoxil | TABLET;ORAL | 021222-001 | Aug 29, 2001 | ⤷ Try a Trial | ⤷ Try a Trial |
Vansen Pharma | SPECTRACEF | cefditoren pivoxil | TABLET;ORAL | 021222-002 | Jul 21, 2008 | ⤷ Try a Trial | ⤷ Try a Trial |
Vansen Pharma | SPECTRACEF | cefditoren pivoxil | TABLET;ORAL | 021222-001 | Aug 29, 2001 | ⤷ Try a Trial | ⤷ Try a Trial |
Vansen Pharma | SPECTRACEF | cefditoren pivoxil | TABLET;ORAL | 021222-002 | Jul 21, 2008 | ⤷ Try a Trial | ⤷ Try a Trial |
Vansen Pharma | SPECTRACEF | cefditoren pivoxil | TABLET;ORAL | 021222-001 | Aug 29, 2001 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription